关注
Dr Sani Uba
Dr Sani Uba
在 abu.edu.ng 的电子邮件经过验证
标题
引用次数
引用次数
年份
Assessment of heavy metals bioavailability in dumpsites of Zaria Metropolis, Nigeria
S Uba, A Uzairu, GFS Harrison, ML Balarabe, OJ Okunola
African Journal of Biotechnology 7 (2), 2008
1222008
Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl-and 2-acylloxyethylsulfonamides as potent anti-fungal agents
Y Isyaku, A Uzairu, S Uba
Heliyon 6 (4), 2020
672020
Quantitative structure-activity relationship and molecular docking studies of a series of quinazolinonyl analogues as inhibitors of gamma amino butyric acid aminotransferase
U Abdulfatai, A Uzairu, S Uba
Journal of advanced research 8 (1), 33-43, 2017
602017
QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
SE Adeniji, S Uba, A Uzairu
Journal of pathogens 2018 (1), 1018694, 2018
522018
Optimization of adsorption of metal ions from a ternary aqueous solution with activated carbon from Acacia senegal (L.) Willd pods using Central Composite Design
AA Adetokun, S Uba, ZN Garba
Journal of King Saud University-Science 31 (4), 1452-1462, 2019
502019
In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents
MT Ibrahim, A Uzairu, GA Shallangwa, S Uba
Heliyon 6 (1), 2020
472020
A rapid method of crude oil analysis using FT-IR spectroscopy
I Abdulkadir, S Uba, MN Almustapha
Nigerian Journal of Basic and Applied Sciences 24 (1), 47-55, 2016
442016
Content of heavy metals in Lumbricus terrestris and associated soils in dump sites
S Uba, A Uzairu, OJ Okunola
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH (IJER) 3 (3), 353-358, 2009
412009
QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: a chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic …
SB Olasupo, A Uzairu, G Shallangwa, S Uba
Journal of the Iranian Chemical Society 17, 1953-1966, 2020
332020
Design of potential anti-melanoma agents against SK-MEL-5 cell line using QSAR modeling and molecular docking methods
AB Umar, A Uzairu, GA Shallangwa, S Uba
SN Applied Sciences 2 (5), 815, 2020
312020
In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative …
SH Abdullahi, A Uzairu, GA Shallangwa, S Uba, AB Umar
Bulletin of the National Research Centre 46 (1), 2, 2022
302022
A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
SE Adeniji, S Uba, A Uzairu, DE Arthur
Advances in preventive medicine 2019 (1), 5173786, 2019
302019
Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor
SE Adeniji, S Uba, A Uzairu
Future Journal of Pharmaceutical Sciences 4 (2), 284-295, 2018
302018
Molecular docking and quantitative structure-activity relationship study of anticonvulsant activity of aminobenzothiazole derivatives
U Abdulfatai, A Uzairu, S Uba
Beni-Suef University Journal of Basic and Applied Sciences 7 (2), 204-214, 2018
292018
Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
AB Umar, A Uzairu, GA Shallangwa, S Uba
Bulletin of the National Research Centre 44, 1-11, 2020
262020
Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach
MT Ibrahim, A Uzairu, GA Shallangwa, S Uba
Scientific African 9, e00503, 2020
262020
Theoretical modeling for predicting the activities of some active compounds as potent inhibitors against Mycobacterium tuberculosis using GFA-MLR approach
SE Adeniji, S Uba, A Uzairu
Journal of King Saud University-Science 32 (1), 575-586, 2020
262020
QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2
AB Umar, A Uzairu, GA Shallangwa, S Uba
Heliyon 6 (3), 2020
242020
Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
MT Ibrahim, A Uzairu, S Uba, GA Shallangwa
Future Journal of Pharmaceutical Sciences 7, 1-11, 2021
232021
In silico evaluation of some 4-(quinolin-2-yl) pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions
AB Umar, A Uzairu, GA Shallangwa, S Uba
Future Journal of Pharmaceutical Sciences 6 (1), 61, 2020
232020
系统目前无法执行此操作,请稍后再试。
文章 1–20